Therapeutic opportunities in Ewing sarcoma: EWS-FLI inhibition via LSD1 targeting
Open Access
- 2 February 2016
- journal article
- review article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (14) , 17616-17630
Abstract
Therapeutic opportunities in Ewing sarcoma: EWS-FLI inhibition via LSD1 targetingKeywords
This publication has 153 references indexed in Scilit:
- The Histone Demethylase KDM1A Sustains the Oncogenic Potential of MLL-AF9 Leukemia Stem CellsCancer Cell, 2012
- Role of androgen receptor and associated lysine‐demethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancerMolecular Carcinogenesis, 2011
- Genome‐wide analysis of ETS‐family DNA‐binding in vitro and in vivoThe EMBO Journal, 2010
- The SNAG domain of Snail1 functions as a molecular hook for recruiting lysine‐specific demethylase 1The EMBO Journal, 2010
- LSD1 Is a Subunit of the NuRD Complex and Targets the Metastasis Programs in Breast CancerCell, 2009
- High-Resolution Profiling of Histone Methylations in the Human GenomeCell, 2007
- Mesenchymal Stem Cell Features of Ewing TumorsCancer Cell, 2007
- Chromatin Modifications and Their FunctionCell, 2007
- Histone H3 Lysine 4 Demethylation Is a Target of Nonselective Antidepressive MedicationsChemistry & Biology, 2006
- Histone Demethylation Mediated by the Nuclear Amine Oxidase Homolog LSD1Cell, 2004